MURUGAPPAN M, BABU B, SHANKAR V, YUSUF M, and JAWAHAR N. “ROLE OF FDA 483 OBSERVATIONS IN QUALITY MANAGEMENT SYSTEMS: ENHANCING COMPLIANCE AND RISK MANAGEMENT”. Asian Journal of Pharmaceutical and Clinical Research 18, no. 4 (April 7, 2025): 44–51. Accessed December 6, 2025. https://www.journals.innovareacademics.in/index.php/ajpcr/article/view/54004.